{
  "id": 16573821,
  "title": "1 in 10 Korean adults used obesity drugs in 2025: report",
  "url": "https://urgent.news/2026/10/26/1-in-10-korean-adults-used-obesity-drugs-in-2025-report",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T08:12:04.000Z",
  "source": {
    "name": "The Korea Times",
    "slug": "the-korea-times-koreatimes",
    "url": "https://www.koreatimes.co.kr/southkorea/health/20261026/1-in-10-korean-adults-used-obesity-drugs-in-2025-report"
  },
  "original_language": "en",
  "account": "According to the \"2026 Korea Wellness Report\" released by KB Financial Group, one in ten adults in Korea used or was prescribed obesity drugs like Wegovy and Mounjaro in the past year. The survey, conducted in July and August, questioned 2,000 men and women aged 25 to 69 and found that 10.3% of respondents used or were prescribed GLP-1 obesity drugs in the last year. Among the different generations, Gen Z, born after 1995, had the highest usage rate at 16.5%, followed by millennials at 14.2%, Generation X at 7.7%, and baby boomers at 2.9%.\n\nMen were more likely to use these drugs than women, with 11.6% of men using them compared to 9% of women. However, women were more aware of the obesity drugs, with 83.1% of women having heard of them compared to 73% of men. When asked about future use, 33.9% of respondents said they would use obesity drugs if circumstances allowed, with this percentage rising to 39.7% among Gen Z respondents. Factors cited for potential future use included appearance and body concerns.",
  "summary": "One in 10 adults in Korea used or was prescribed obesity drugs such as Wegovy and Mounjaro in the past year, with younger generations reporting higher usage and one-third of respondents saying they would use such drugs in the future. According to the “2026 Korea Wellness Report” released Sunday by KB Financial Group, 10.3 percent of the 2,000 men and women aged 25 to 69 who were surveyed in July…",
  "key_points": [
    "10.3% of Korean adults used GLP-1 obesity drugs in 2025",
    "Gen Z had the highest usage rate at 16.5%",
    "Women were more aware of obesity drugs than men"
  ],
  "editors_take": "The rising adoption of GLP-1 medications among younger Koreans signals a shift toward pharmaceutical weight management driven by body image concerns and aesthetic motivations.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}